title: [Antiarrhythmic therapy--recent aspects of pharmacologic treatment].
abstract: Over the last years the indication for antiarrhythmic therapy has changed due to the development of other therapeutic approaches. However, antiarrhythmics are important in the acute treatment as well as the prevention of recurrent rhythm disorders. In line with the antiarrhythmic agents of class IC and III also beta-blockers, ACE inhibitors and AT (1) antagonists can be used primarily with a lower risk of severe cardiac side effects. Recent studies demonstrate that for patients with atrial fibrillation there was no benefit of rhythm control versus rate control. However, rhythm control with antiarrhythmics is beneficial in the treatment of highly symptomatic or hemodynamically compromised patients. Hybrid therapy and the "pill in the pocket"-strategy seem to be potent new therapeutic options.
authors.affiliation: Universitäres Herzzentrum, Kardiologie,Universitätsklinikum Hamburg-Eppendorf, Hamburg. patten@uke.uni-hamburg.de
authors.forename: M
authors.initials: M
authors.lastname: Patten
authors.forename: T
authors.initials: T
authors.lastname: Meinertz
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006801:Humans
chemical_list: D000889:Anti-Arrhythmia Agents